Skip to main content
Erschienen in: Digestive Diseases and Sciences 12/2018

04.07.2018 | Original Article

Effect of Homocysteine on the Differentiation of CD4+ T Cells into Th17 Cells

verfasst von: Xin Gao, Jin Li, Min Chen

Erschienen in: Digestive Diseases and Sciences | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

The hyperhomocysteinaemia (Hhcy) is a common phenomenon observed in patients with inflammatory bowel disease (IBD). Our previous study showed that Hhcy aggravated intestinal inflammation in an animal model of colitis. Increased levels of IL-17 and RORγt were also observed in this animal model of colitis with Hhcy. However, the direct effect of homocysteine on the differentiation of Th17 cells has never been studied. The aim of this study was to investigate the direct effect of Hhcy on the differentiation of CD4+ T cells into Th17 cells.

Method

Lamina propria lymphocytes (LPLs) in colonic mucosa of Wistar rats were isolated and cultured under Th17-inducing (iTH17) environments. Different concentrations of the Hcy (0–100 μmol/ml) were added alone or combined with IL-23 (100 ng/ml) or folate (5 μmol/ml). The LPLs were divided into eight groups as follows: (1) Control group; (2) 10 μmol/ml Hcy group; (3) 25 μmol/ml Hcy group; (4) 50 μmol/ml Hcy group; (5) 100 μmol/ml Hcy group; (6) 100 ng/ml IL-23 group; (7) 50 μmol/ml Hcy + 100 ng/ml IL-23 group and (8) 50 μmol/ml Hcy + 100 ng/ml IL-23 + 5 μmol/ml folate group. The protein expression levels of IL-17, retinoid-related orphan nuclear receptor-γt (RORγt), p38 MAPK, phosphorylated p38 MAPK, cytosolic phospholipase A2 (cPLA2), phosphorylated-cPLA2 and cyclooxygenase 2 (COX2) were detected by immunoblot analysis. The protein level of prostaglandin E2 (PGE2) and IL-17 was detected by ELISA, and IL-17 and RORγt-positive CD4+ T cells were stained and analyzed by flow cytometry.

Results

Hcy increased the protein levels of IL-17, RORγt, the ratio of phosphorylated p38 MAPK to p38 MAPK (p-p38/p38), the ratio of phosphorylated cPLA2 to cPLA2 (p-cPLA2/cPLA2) and COX2. The effect was concentration dependent to a certain degree; Hcy of 50 μmol/ml was the optimal concentration to increase the protein levels of those molecules. The level of IL-17 and PGE2 in the cell culture supernatants and the expression of IL-17 and RORγt in positive CD4+ T cells were also increased in the group of Hhcy. IL-23 showed a cooperative effect with Hcy on the differentiation of CD4+ Th cells into Th17 cells, whereas folate supplementation showed an inhibition action.

Conclusions

Homocysteine promoted the differentiation of CD4+ T cells into Th17 cells in a dose-dependant manner. This effect could be inhibited by folate.
Literatur
1.
Zurück zum Zitat Soubieres AA, Poullis A. Emerging biomarkers for the diagnosis and monitoring of inflammatory bowel diseases. Inflamm Bowel Dis. 2016;22:2016–2022.CrossRef Soubieres AA, Poullis A. Emerging biomarkers for the diagnosis and monitoring of inflammatory bowel diseases. Inflamm Bowel Dis. 2016;22:2016–2022.CrossRef
2.
Zurück zum Zitat Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627–1640.CrossRef Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627–1640.CrossRef
3.
Zurück zum Zitat Patel DD, Kuchroo VK. Th17 cell pathway in human immunity: lessons from genetics and therapeutic interventions. Immunity. 2015;43:1040–1051.CrossRef Patel DD, Kuchroo VK. Th17 cell pathway in human immunity: lessons from genetics and therapeutic interventions. Immunity. 2015;43:1040–1051.CrossRef
4.
Zurück zum Zitat Friedrich M, Diegelmann J, Schauber J, et al. Intestinal neuroendocrine cells and goblet cells are mediators of IL-17A-amplified epithelial IL-17C production in human inflammatory bowel disease. Mucosal Immunol. 2015;8:943–958.CrossRef Friedrich M, Diegelmann J, Schauber J, et al. Intestinal neuroendocrine cells and goblet cells are mediators of IL-17A-amplified epithelial IL-17C production in human inflammatory bowel disease. Mucosal Immunol. 2015;8:943–958.CrossRef
5.
Zurück zum Zitat Ray S, De Salvo C, Pizarro TT. Central role of IL-17/Th17 immune responses and the gut microbiota in the pathogenesis of intestinal fibrosis. Curr Opin Gastroenterol. 2014;30:531–538.CrossRef Ray S, De Salvo C, Pizarro TT. Central role of IL-17/Th17 immune responses and the gut microbiota in the pathogenesis of intestinal fibrosis. Curr Opin Gastroenterol. 2014;30:531–538.CrossRef
6.
Zurück zum Zitat Honzawa Y, Nakase H, Shiokawa M, et al. Involvement of interleukin-17A-induced expression of heat shock protein 47 in intestinal fibrosis in Crohn’s disease. Gut. 2014;63:1902–1912.CrossRef Honzawa Y, Nakase H, Shiokawa M, et al. Involvement of interleukin-17A-induced expression of heat shock protein 47 in intestinal fibrosis in Crohn’s disease. Gut. 2014;63:1902–1912.CrossRef
7.
Zurück zum Zitat Zenewicz LA, Antov A, Flavell RA. CD4 T-cell differentiation and inflammatory bowel disease. Trends Mol Med. 2009;15:199–207.CrossRef Zenewicz LA, Antov A, Flavell RA. CD4 T-cell differentiation and inflammatory bowel disease. Trends Mol Med. 2009;15:199–207.CrossRef
8.
Zurück zum Zitat Fossiez F, Djossou O, Chomarat P, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med. 1996;183:2593–2603.CrossRef Fossiez F, Djossou O, Chomarat P, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med. 1996;183:2593–2603.CrossRef
9.
Zurück zum Zitat Nalbant A, Eskier D. Genes associated with T helper 17 cell differentiation and function. Front Biosci. 2016;8:427–435.CrossRef Nalbant A, Eskier D. Genes associated with T helper 17 cell differentiation and function. Front Biosci. 2016;8:427–435.CrossRef
10.
Zurück zum Zitat Bettelli E, Oukka M, Kuchroo VK. TH-17 cells in the circle of immunity and autoimmunity. Nat Immunol. 2007;4:345–350.CrossRef Bettelli E, Oukka M, Kuchroo VK. TH-17 cells in the circle of immunity and autoimmunity. Nat Immunol. 2007;4:345–350.CrossRef
11.
Zurück zum Zitat Kallel L, Feki M, Sekri W, et al. Prevalence and risk factors of hyperhomocysteinemia in Tunisian patients with Crohn’s disease. J Crohns Colitis. 2011;5:110–114.CrossRef Kallel L, Feki M, Sekri W, et al. Prevalence and risk factors of hyperhomocysteinemia in Tunisian patients with Crohn’s disease. J Crohns Colitis. 2011;5:110–114.CrossRef
12.
Zurück zum Zitat Peyrin-Biroulet L, Gueant-Rodriguez RM, Chen M, et al. Association of MTRR 66A > G polymorphism with superoxide dismutase and disease activity in patients with Crohn’s disease. Am J Gastroenterol. 2008;103:399–406.CrossRef Peyrin-Biroulet L, Gueant-Rodriguez RM, Chen M, et al. Association of MTRR 66A > G polymorphism with superoxide dismutase and disease activity in patients with Crohn’s disease. Am J Gastroenterol. 2008;103:399–406.CrossRef
13.
Zurück zum Zitat Danese S, Sgambato A, Papa A, et al. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am J Gastroenterol. 2005;100:886–895.CrossRef Danese S, Sgambato A, Papa A, et al. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am J Gastroenterol. 2005;100:886–895.CrossRef
14.
Zurück zum Zitat Zhu S, Li J, Bing Y, et al. Diet-induced hyperhomocysteinaemia increases intestinal inflammation in an animal model of colitis. J Crohn’s Colitis. 2015;9:708–719.CrossRef Zhu S, Li J, Bing Y, et al. Diet-induced hyperhomocysteinaemia increases intestinal inflammation in an animal model of colitis. J Crohn’s Colitis. 2015;9:708–719.CrossRef
15.
Zurück zum Zitat Reissig S, Hackenbruch C, Hovelmeyer N. Isolation of T cells from the gut. Methods Mol Biol. 2014;1193:21–25.CrossRef Reissig S, Hackenbruch C, Hovelmeyer N. Isolation of T cells from the gut. Methods Mol Biol. 2014;1193:21–25.CrossRef
16.
Zurück zum Zitat Weigmann B, Tubbe I, Seidel D, et al. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat Protoc. 2007;2:2307–2311.CrossRef Weigmann B, Tubbe I, Seidel D, et al. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat Protoc. 2007;2:2307–2311.CrossRef
17.
Zurück zum Zitat Di Sabatino A, Pender SL, Jackson CL, et al. Functional modulation of Crohn’s disease myofibroblasts by anti-tumor necrosis factor antibodies. Gastroenterology. 2007;133:137–149.CrossRef Di Sabatino A, Pender SL, Jackson CL, et al. Functional modulation of Crohn’s disease myofibroblasts by anti-tumor necrosis factor antibodies. Gastroenterology. 2007;133:137–149.CrossRef
18.
Zurück zum Zitat Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor ROR gammat directs the differentiation program of proinflammatory IL-17 + T helper cells. Cell. 2006;126:1121–1133.CrossRef Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor ROR gammat directs the differentiation program of proinflammatory IL-17 + T helper cells. Cell. 2006;126:1121–1133.CrossRef
19.
Zurück zum Zitat Donaldson DS, Bradford BM, Artis D, et al. Reciprocal regulation of lymphoid tissue development in the large intestine by IL-25 and IL-23. Mucosal Immunol. 2015;8:582–595.CrossRef Donaldson DS, Bradford BM, Artis D, et al. Reciprocal regulation of lymphoid tissue development in the large intestine by IL-25 and IL-23. Mucosal Immunol. 2015;8:582–595.CrossRef
20.
Zurück zum Zitat Schicho R, Marsche G, Storr M. Cardiovascular complications in inflammatory bowel disease. Curr Drug Targets. 2015;16:181–188.CrossRef Schicho R, Marsche G, Storr M. Cardiovascular complications in inflammatory bowel disease. Curr Drug Targets. 2015;16:181–188.CrossRef
21.
Zurück zum Zitat Keshteli AH, Baracos VE, Madsen KL. Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review. World J Gastroenterol. 2015;21:1081–1090.CrossRef Keshteli AH, Baracos VE, Madsen KL. Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review. World J Gastroenterol. 2015;21:1081–1090.CrossRef
22.
Zurück zum Zitat Casella G, Antonelli E, Di Bella C, et al. Hyperhomocysteinemia in patients with Crohn’s disease. Tech Coloproctol. 2013;17:497–500.CrossRef Casella G, Antonelli E, Di Bella C, et al. Hyperhomocysteinemia in patients with Crohn’s disease. Tech Coloproctol. 2013;17:497–500.CrossRef
23.
Zurück zum Zitat Feng J, Lu S, Ding Y, et al. Homocysteine activates T cells by enhancing endoplasmic reticulum-mitochondria coupling and increasing mitochondrial respiration. Protein Cell. 2016;7:391–402.CrossRef Feng J, Lu S, Ding Y, et al. Homocysteine activates T cells by enhancing endoplasmic reticulum-mitochondria coupling and increasing mitochondrial respiration. Protein Cell. 2016;7:391–402.CrossRef
24.
Zurück zum Zitat Andersohn F, Waring M, Garbe E. Risk of ischemic stroke in patients with Crohn’s disease: a population-based nested case-control study. Inflamm Bowel Dis. 2010;16:1387–1392.CrossRef Andersohn F, Waring M, Garbe E. Risk of ischemic stroke in patients with Crohn’s disease: a population-based nested case-control study. Inflamm Bowel Dis. 2010;16:1387–1392.CrossRef
25.
Zurück zum Zitat Peyrin-Biroulet L, Rodriguez-Gueant RM, Chamaillard M, et al. Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine. Am J Gastroenterol. 2007;102:1108–1115.CrossRef Peyrin-Biroulet L, Rodriguez-Gueant RM, Chamaillard M, et al. Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine. Am J Gastroenterol. 2007;102:1108–1115.CrossRef
26.
Zurück zum Zitat Guilland JC, Favier A, Potier DCG, et al. Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease? Pathol Biol. 2003;51:101–110.CrossRef Guilland JC, Favier A, Potier DCG, et al. Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease? Pathol Biol. 2003;51:101–110.CrossRef
27.
Zurück zum Zitat Oussalah A, Gueant JL, Peyrin-Biroulet L. Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases. Aliment Pharmacol Ther. 2011;34:1173–1184.CrossRef Oussalah A, Gueant JL, Peyrin-Biroulet L. Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases. Aliment Pharmacol Ther. 2011;34:1173–1184.CrossRef
28.
Zurück zum Zitat Ding H, Mei Q, Gan HZ, et al. Effect of homocysteine on intestinal permeability in rats with experimental colitis, and its mechanism. Gastroenterol Rep. 2014;2:215–220.CrossRef Ding H, Mei Q, Gan HZ, et al. Effect of homocysteine on intestinal permeability in rats with experimental colitis, and its mechanism. Gastroenterol Rep. 2014;2:215–220.CrossRef
29.
Zurück zum Zitat Gaffen SL, Jain R, Garg AV, et al. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol. 2014;14:585–600.CrossRef Gaffen SL, Jain R, Garg AV, et al. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol. 2014;14:585–600.CrossRef
30.
Zurück zum Zitat Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573–621.CrossRef Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573–621.CrossRef
31.
Zurück zum Zitat Abraham C, Cho J. Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:1090–1100.CrossRef Abraham C, Cho J. Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:1090–1100.CrossRef
32.
Zurück zum Zitat Maloy KJ. The Interleukin-23/Interleukin-17 axis in intestinal inflammation. J Intern Med. 2008;263:584–590.CrossRef Maloy KJ. The Interleukin-23/Interleukin-17 axis in intestinal inflammation. J Intern Med. 2008;263:584–590.CrossRef
33.
Zurück zum Zitat Cox JH, Kljavin NM, Ota N, et al. Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice. Mucosal Immunol. 2012;5:99–109.CrossRef Cox JH, Kljavin NM, Ota N, et al. Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice. Mucosal Immunol. 2012;5:99–109.CrossRef
34.
Zurück zum Zitat Mahmud N, Molloy A, McPartlin J, et al. Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications. Gut. 1999;45:389–394.CrossRef Mahmud N, Molloy A, McPartlin J, et al. Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications. Gut. 1999;45:389–394.CrossRef
35.
Zurück zum Zitat Cianciulli A, Salvatore R, Porro C, et al. Folic acid is able to polarize the inflammatory response in LPS activated microglia by regulating multiple signaling pathways. Mediat Inflamm. 2016;2016:1–10.CrossRef Cianciulli A, Salvatore R, Porro C, et al. Folic acid is able to polarize the inflammatory response in LPS activated microglia by regulating multiple signaling pathways. Mediat Inflamm. 2016;2016:1–10.CrossRef
36.
Zurück zum Zitat Wang N, Tang H, Wang X, et al. Homocysteine upregulates interleukin-17A expression via NSun2-mediated RNA methylation in T lymphocytes. Biochem Biophys Res Commun. 2017;493:94–99.CrossRef Wang N, Tang H, Wang X, et al. Homocysteine upregulates interleukin-17A expression via NSun2-mediated RNA methylation in T lymphocytes. Biochem Biophys Res Commun. 2017;493:94–99.CrossRef
37.
Zurück zum Zitat Geginat J, Paroni M, Kastirr I, et al. Reverse plasticity: TGF-beta and IL-6 induce Th1-to-Th17-cell transdifferentiation in the gut. Eur J Immunol. 2016;46:2306–2310.CrossRef Geginat J, Paroni M, Kastirr I, et al. Reverse plasticity: TGF-beta and IL-6 induce Th1-to-Th17-cell transdifferentiation in the gut. Eur J Immunol. 2016;46:2306–2310.CrossRef
Metadaten
Titel
Effect of Homocysteine on the Differentiation of CD4+ T Cells into Th17 Cells
verfasst von
Xin Gao
Jin Li
Min Chen
Publikationsdatum
04.07.2018
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 12/2018
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5177-2

Weitere Artikel der Ausgabe 12/2018

Digestive Diseases and Sciences 12/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.